Advertisement
YOU ARE HERE: LAT HomeCollectionsAmgen

BRIEFLY

Drug Reimbursements Approved: The federal Health Care...

June 23, 1989

Drug Reimbursements Approved: The federal Health Care Financing Administration has agreed to reimburse kidney dialysis centers when patients use Amgen Inc.'s new Epogen drug, retroactive to June 1. Epogen is the brand name for erythropoietin, a protein developed by the Thousand Oaks biotechnology company that is used to treat chronic anemia by stimulating production of red blood cells. Amgen said the U.S. will reimburse about 80% of a patient's treatment costs, with states covering the balance.

Advertisement
Los Angeles Times Articles
|
|
|